| Application no. and date | 15765287.6 (espacenet) (Federated) (European Patent Register), 20150320 | | Patent/reg. no. and date | DK/EP 3119431, 20240124 | | Publication date | 20170125 | | Priority no. and date | US 201461968897 P, 20140321, US 201462083809 P, 20141124, US 201562119778 P, 20150223 | | EP pub. no. and date |
EP 3119431 20170125 | | Effective date | | | Applicant/owner | Teva Pharmaceuticals International GmbH, Schlüsselstrasse 12
8645 Rapperswil-Jona, CH | | Applicant ref. no. | P83938DK01 | | Inventor | Walter, Sarah, 2615 Delaware Avenue
Redwood City, CA 94061, US,
BIGAL, Marcelo, 4269 Arbor Lane
Doylestown, PA 18902, US,
STERN, Henry, 13060 Skyline Boulevard
Woodside, CA 94062, US,
CHANG, Michael, 135 Shawnee Pass
Portola Valley, CA 94028, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) | | Title | ANTAGONISTANTISTOFFER RETTET MOD CALCITONINGEN-RELATERET PEPTID OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Int. application no. | US2015021887 | | Int. publication no. | WO2015143409 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
